Literature DB >> 21666425

Irritable bowel syndrome and other functional gastrointestinal disorders.

Ilkay Şimşek1.   

Abstract

Irritable bowel syndrome is one of several highly prevalent functional gastrointestinal disorders (FGID) displaying symptoms of gastrointestinal dysmotility and visceral hypersensitivity. Substantial overlap of symptoms and comorbidities occur not only between irritable bowel syndrome and other FGID but also with gastrointestinal disorders that are not related to motility (eg, celiac disease and lactose intolerance) and to somatic conditions (eg, fibromyalgia and chronic fatigue syndrome). Pathogenic mechanisms common among FGIDs may include alternations in intestinal and colonic microflora. Evidence is also emerging of an interplay between gut immune cells/activity and alternations in motility, secretion, and sensation. The role of cytokine activity and inflammation is important in this regard. As recommended by Rome III, diagnostic testing should be guided by the patient's age, primary symptom characteristics, and other clinical and laboratory features. The high prevalence of coexisting conditions suggests the need to routinely assess patients for related disorders. Treatment should be based on an individualized evaluation, explanation, and reassurance.

Entities:  

Mesh:

Year:  2011        PMID: 21666425     DOI: 10.1097/MCG.0b013e31821fbd6f

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

Review 1.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

Review 2.  Immunoinflammation and functional gastrointestinal disorders.

Authors:  Ming-Kai Chen; Shu-Zhong Liu; Li Zhang
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

3.  Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database Study.

Authors:  Tse-Yen Yang; Chih-Sheng Chen; Cheng-Li Lin; Wei-Ming Lin; Chua-Nan Kuo; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 4.  Is There a Correlation Between Irritable Bowel Syndrome and Lactose Intolerance?

Authors:  Ivan Cancarevic; Mahnoor Rehman; Beshoy Iskander; Sanee Lalani; Bilal Haider Malik
Journal:  Cureus       Date:  2020-01-20

5.  Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?

Authors:  Dwaipayan Sarathi Chakraborty; Avijit Hazra; Amrita Sil; Shantasil Pain
Journal:  J Family Med Prim Care       Date:  2019-10-31

Review 6.  Giardia spp. and the Gut Microbiota: Dangerous Liaisons.

Authors:  Elena Fekete; Thibault Allain; Affan Siddiq; Olivia Sosnowski; Andre G Buret
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

7.  Effects of milk containing only A2 beta casein versus milk containing both A1 and A2 beta casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows' milk.

Authors:  Sun Jianqin; Xu Leiming; Xia Lu; Gregory W Yelland; Jiayi Ni; Andrew J Clarke
Journal:  Nutr J       Date:  2016-04-02       Impact factor: 3.271

8.  Risk for irritable bowel syndrome in fibromyalgia patients: a national database study.

Authors:  Tse-Yen Yang; Chih-Sheng Chen; Cheng-Li Lin; Wei-Ming Lin; Chua-Nan Kuo; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

9.  Effect of cognitive behavior therapy combined with exercise intervention on the cognitive bias and coping styles of diarrhea-predominant irritable bowel syndrome patients.

Authors:  Shi-Rui Zhao; Xiao-Mei Ni; Xin-An Zhang; Hong Tian
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.